# Clinical Evaluation of Simcyp-Guided Simvastatin Dosing in Patients With Liver Cirrhosis

> **NCT07459972** · PHASE4 · COMPLETED · sponsor: **Kafrelsheikh University** · enrollment: 22 (actual)

## Conditions studied

- Liver Cirrhosis
- Portal Hypertension Related to Cirrhosis

## Interventions

- **DRUG:** Simvastatin 15 mg
- **DRUG:** Simvastatin 5 mg

## Key facts

- **NCT ID:** NCT07459972
- **Lead sponsor:** Kafrelsheikh University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-03-15
- **Primary completion:** 2025-03-15
- **Final completion:** 2025-06-15
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2026-03-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07459972

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07459972, "Clinical Evaluation of Simcyp-Guided Simvastatin Dosing in Patients With Liver Cirrhosis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT07459972. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*